Document Detail


Short-term isotretinoin treatment decreases insulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels: does isotretinoin affect growth hormone physiology?
MedLine Citation:
PMID:  20128787     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Isotretinoin is an effective treatment for acne vulgaris. However, it has numerous side-effects. It was previously reported that serum growth hormone (GH) levels decreased with isotretinoin treatment. OBJECTIVES: To analyse whether isotretinoin has any effects on insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP3) and GH levels. METHODS: Forty-seven patients aged 21.5 +/- 5.1 years (mean +/- SD) with acne vulgaris were included in this study. Isotretinoin therapy was initiated at a dose of 0.5-0.75 mg kg(-1) daily and then adjusted to 0.88 mg kg(-1) daily as maintenance dosage after 1 month. Screening for biochemical and hormonal parameters was performed just before initiation and after 3 months of isotretinoin treatment. RESULTS: IGF-1 and IGFBP3 levels decreased significantly after treatment (P < 0.01), while GH levels did not change. Post-treatment, significant increases were seen in aspartate aminotransferase, total cholesterol, low-density lipoprotein cholesterol, triglycerides and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio (P < 0.0001) while high-density lipoprotein cholesterol levels were significantly decreased (P < 0.0001). CONCLUSIONS: Isotretinoin therapy may have an effect on GH physiology, and further studies are needed to understand this association.
Authors:
A S Karadag; D T Ertugrul; E Tutal; K O Akin
Related Documents :
15939107 - Low-density lipoprotein cholesterol estimation by a new formula in indian population.
11314287 - Predictors of plasma triglyceride elevation in patients participating in a coronary ath...
11171287 - Common genetic variants that relate to disorders of lipid transport in spanish subjects...
20636707 - Relationship between serum lipid values and atherosclerotic burden in the proximal thor...
Publication Detail:
Type:  Journal Article     Date:  2010-02-01
Journal Detail:
Title:  The British journal of dermatology     Volume:  162     ISSN:  1365-2133     ISO Abbreviation:  Br. J. Dermatol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-05-26     Completed Date:  2010-10-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0004041     Medline TA:  Br J Dermatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  798-802     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Keçiören Research and Training Hospital, 06290 Keçiören, Ankara, Turkey. drayserem@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acne Vulgaris / blood,  drug therapy*
Adolescent
Dermatologic Agents / therapeutic use*
Female
Human Growth Hormone / blood*,  drug effects,  physiology
Humans
Insulin-Like Growth Factor Binding Protein 3 / blood*
Insulin-Like Growth Factor I / metabolism*
Isotretinoin / therapeutic use*
Male
Reference Values
Young Adult
Chemical
Reg. No./Substance:
0/Dermatologic Agents; 0/Insulin-Like Growth Factor Binding Protein 3; 12629-01-5/Human Growth Hormone; 4759-48-2/Isotretinoin; 67763-96-6/Insulin-Like Growth Factor I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A conceptual framework for the colonisation of urban areas: the blackbird Turdus merula as a case st...
Next Document:  Epidermolysis bullosa simplex due to KRT5 mutations: mutation-related differences in cellular fragil...